Jeffrey Sherman

Track

Insider profile

Currently holds a position at Xeris Pharmaceuticals Inc

Performance

Overall performance
3.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 3% 68% 82%
Transactions
3 67% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 324%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Independent Director Xeris Pharmaceuticals Inc April 1, 2018 -
Executive Vice President, Chief Medical Officer Horizon Therapeutics PLC Jan. 1, 2018 - Jan. 1, 2019
Executive Vice President - Research and Development and Chief Medical Officer Horizon Therapeutics PLC Sept. 1, 2014 - Jan. 1, 2018
Jeffrey Sherman's trades of Larimar Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
485.13
Quantity 26,670
Value US$2,757,056
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-02 2026-02-27
B Purchase
28,275 +31.4%
92.30
US$69,227 		28,275 +31.4% 92.30 US$69,227
2025-08-29 2025-08-28
S Sale
81,412 +4.9%
388.13
US$3,100,267 		81,412 +4.9% 388.13 US$3,100,267
2025-08-28 2025-08-28
PrS Proposed sale
26,670
485.13
US$2,757,056 		26,670 485.13 US$2,757,056
2023-11-29 2023-11-27
B Purchase
5,400 +inf%
1.87
US$10,098 		5,400 +inf% 1.87 US$10,098
2023-01-12 2023-01-11
PlS Planned sale
3,368 -8.5%
113.10
US$380,921 		3,368 -8.5% 113.10 US$380,921
2023-01-12 2023-01-10
PlS Planned sale
3,368 -7.8%
113.05
US$380,752 		3,368 -7.8% 113.05 US$380,752
2023-01-06 2023-01-06
PlS Planned sale
5,187 -9.5%
113.29
US$587,635 		5,187 -9.5% 113.29 US$587,635
2022-12-13 2022-12-12
PlS Planned sale
21,378 -20.2%
111.45
US$2,382,484 		21,378 -20.2% 111.45 US$2,382,484
2022-12-13 2022-12-12
PlS Planned sale
6,974 -11.3%
111.44
US$777,208 		6,974 -11.3% 111.44 US$777,208
2022-04-08 2022-04-06
PlS Planned sale
42,009 -79.8%
110.02
US$4,621,872 		42,009 -79.8% 110.02 US$4,621,872
2020-12-09 2020-12-08
PlS Planned sale
31,133 -15.1%
71.32
US$2,220,406 		31,133 -15.1% 71.32 US$2,220,406
2020-12-09 2020-12-08
PlS Planned sale
9,631 -4.5%
70.60
US$679,949 		9,631 -4.5% 70.60 US$679,949
2020-12-09 2020-12-07
PlS Planned sale
10,489 -4.6%
72.24
US$757,725 		10,489 -4.6% 72.24 US$757,725
2020-12-09 2020-12-07
PlS Planned sale
16,200 -6.7%
71.52
US$1,158,624 		16,200 -6.7% 71.52 US$1,158,624
2020-12-09 2020-12-07
PlS Planned sale
36,389 -13.1%
70.31
US$2,558,511 		36,389 -13.1% 70.31 US$2,558,511
2020-07-07 2020-07-06
PlS Planned sale
9,100 -3.2%
57.50
US$523,250 		9,100 -3.2% 57.50 US$523,250
2020-05-12 2020-05-11
PlS Planned sale
33,479 -70.6%
45.00
US$1,506,555 		33,479 -70.6% 45.00 US$1,506,555
2016-08-02 2016-08-02
PlS Planned sale
2,900 -1.8%
20.00
US$58,000 		2,900 -1.8% 20.00 US$58,000
2004-05-19 2004-05-17
B Purchase
100 +0.0%
14.06
US$1,406 		100 +0.0% 14.06 US$1,406